Erin Trish, Elizabeth Fowler, and Paul Ginsburg discussed the future of value-based payment models at a recent webinar viewed by over 500 people.
Part 3 of a panel series on health care price regulation honoring Uwe E. Reinhardt (1937-2017)
Part 2 of a panel series on healthcare price regulation honoring Uwe E. Reinhardt (1937-2017)
Scholars from the USC-Brookings Schaeffer Initiative for Health Policy Georgia’s latest 1332 Proposal, analyzing its major analytical errors and procedural deficiencies that render it unapprovable.
This analysis highlights that most cost-utility analyses that cite high cost-effectiveness thresholds also result in greater incremental cost-effectiveness ratios for the novel interventions that they investigate.
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Fixed indemnity products are offered in problematic and nontransparent ways in the individual market for health insurance and by employers offering coverage to their workers.
To protect Californians from rising health care costs, the state needs to strengthen price transparency and price competition, according to Melnick.
What changes should be made now to the U.S. healthcare system to make it better when things return to a new normal, and, in the event of future pandemics.
Christen Linke Young explains the dangers of junk insurance.